Renee H. Raynor

Assessing Discrepancies in Neurocognitive and Patient-Reported Measures of Brain Tumor Survivors

Deborah Allen, Barbara W. Carlson, John S. Carlson, Renee H. Raynor et autres

OBJECTIVES: To examine the association between performance-based neurocognitive and patient-reported cognitive function tests and identify characteristics that may explain observed discrepancies as a means to advance intervention development. SAMPLE & SETTING: 40 adults diagnosed with a primary brain tumor (PBT) (high-grade, n …

us (code pays fourni par la source)

Quality of Life

M. R. Lucas, Terri S. Armstrong, A. Acquaye, Diwakar D. Balachandran et autres

\n Contains fulltext :\n 112541.pdf (Publisher’s version ) (Closed access)\n

Support services

Bebe Guill, Renee H. Raynor

Introduction Whether the primary treatment approach to cognitive impairment in cancer is remediation/rehabilitation, pharmacotherapy, or a combination, one must not underestimate the importance of comprehensive support services throughout the illness continuum. Cognitive deficits related to cancer may be primary, related to the …

Dose-Dependent Effects of Radiation Therapy on Cerebral Blood Flow, Metabolism, and Neurocognitive Dysfunction

Carol A. Hahn, Renee H. Raynor, Andrea Tisch, K. Light et autres

us (code pays fourni par la source)

Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors

Staci D. Arnold, Leslie M. Forman, Bart D. Brigidi, Karen E. Carter et autres

To determine clinical and sociodemographic factors that are associated with major neuropsychiatric illnesses among brain tumor patients, we administered a modified version of the Brief Patient Health Questionnaire and a demographic data form to 363 adult neuro-oncology patients. Responses were analyzed to …

us (code pays fourni par la source)

A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

David A. Reardon, Michael R. Zalutsky, Gamal Akabani, R. Edward Coleman et autres

The purpose of this study was to determine the feasibility and assess the efficacy and toxicity, among newly diagnosed malignant glioma patients, of administering (131)I-labeled murine antitenascin monoclonal antibody 81C6 ((131)I-81C6) into a surgically created resection cavity (SCRC) to achieve a patient-specific, …

us (code pays fourni par la source)

A Randomized Prospective Trial of the Effect of Video Radiation Oncology Education on Patient Anxiety

Carol A. Hahn, Renee H. Raynor, Laura J. Fish, Jeannette M. Day et autres

us (code pays fourni par la source)